Pantoprazole IV (Pantoprazole)

Pantoprazole IV (Pantoprazole for Injection) is a proton pump inhibitor (PPI) that works by selectively blocking the H+/K+ ATPase enzyme system at the gastric parietal cell surface, thereby reducing gastric acid secretion. It is indicated for patients who require short-term treatment of acid-related disorders when oral administration is not possible.

Key therapeutic uses include:

• Gastroesophageal Reflux Disease (GERD): Treatment of erosive esophagitis associated with acid reflux.

• Zollinger-Ellison Syndrome & Pathological Hypersecretory Conditions: Control of excessive gastric acid production.

• Peptic Ulcer & Stress Ulcer Prophylaxis (hospitalized/critically ill patients).

Pantoprazole IV provides rapid symptom relief and mucosal healing, especially in acute care or inpatient settings. It is typically administered by intravenous injection or infusion, and therapy may be transitioned to oral pantoprazole once the patient can tolerate oral intake.

Key Features:

• Fast-acting IV formulation for hospitalized patients.

• Effective acid suppression in acute and severe cases.

• Generally well-tolerated with a favorable safety profile.